bpc 157 human clinical trials 2024 2025 BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers BPC-157 FDA Approval Status: Is
Description
You just need to use less water
For research protocols that require multiple accesses to a vial, bacteriostatic water is strongly preferred
PubMed Sikiric P, et al
Despite that, many companies that market NAD+ are calling it NAD+ peptide
